Cargando…

“Is Fosfomycin As Effective As Claimed On MDR Gram-Negative Bacteria Causing UTI?” [Response To Letter]

Detalles Bibliográficos
Autores principales:	Gopichand, Pallam, Agarwal, Girija, Natarajan, Mailan, Mandal, Jharna, Deepanjali, Surendran, Parameswaran, Sreejith, Dorairajan, LN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Response to Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781579/ https://www.ncbi.nlm.nih.gov/pubmed/31632099 http://dx.doi.org/10.2147/IDR.S231341

Ejemplares similares

In vitro effect of fosfomycin on multi-drug resistant gram-negative bacteria causing urinary tract infections
por: Gopichand, Pallam, et al.
Publicado: (2019)

Is fosfomycin as effective as claimed on MDR Gram-negative bacteria causing UTI? [Letter]
por: Singh, Geeta, et al.
Publicado: (2019)

An outbreak of Salmonella Enteritidis food poisoning following consumption of chicken shawarma: A brief epidemiological investigation
por: Deepanjali, Surendran, et al.
Publicado: (2022)

Use of fosfomycin combination therapy to treat multidrug-resistant urinary tract infection among paediatric surgical patients – a tertiary care centre experience
por: K.S., Shiju, et al.
Publicado: (2020)

Fosfomycin versus Nitrofurantoin for the Treatment of Lower UTI in Outpatients
por: Sharma, Shraddha, et al.
Publicado: (2021)

The Emergence of Quinolone Resistant Shigella sonnei, Pondicherry, India
por: Das, Ankita, et al.
Publicado: (2016)

A study of virulence and antimicrobial resistance pattern in diarrhoeagenic Escherichia coli isolated from diarrhoeal stool specimens from children and adults in a tertiary hospital, Puducherry, India
por: Natarajan, Mailan, et al.
Publicado: (2018)

Stopping the effective non-fluoroquinolone antibiotics at day 7 vs continuing until day 14 in adults with acute pyelonephritis requiring hospitalization: A randomized non-inferiority trial
por: Rudrabhatla, Pavankumar, et al.
Publicado: (2018)

Susceptibility pattern of oral antimicrobials in uncomplicated UTI: Does fosfomycin still stand effective?
por: Batra, Priyam, et al.
Publicado: (2020)

Reevaluating the true diagnostic accuracy of dipstick tests to diagnose urinary tract infection using Bayesian latent class analysis
por: Bafna, Prashant, et al.
Publicado: (2020)

Response: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52)
por: Suh, Sunghwan, et al.
Publicado: (2015)

Response: Trends in Hyperglycemic Crisis Hospitalizations and in- and out-of-Hospital Mortality in the Last Decade Based on Korean National Health Insurance Claims Data (Endocrinol Metab 2019;34:275–81, Ji Hong You et al.)
por: You, Ji Hong, et al.
Publicado: (2019)

1524. Are Providers Shifting from NTF to Fosfomycin for Inpatient UTI? Big Data Reveals Small Shifts
por: Gupta, Kalpana, et al.
Publicado: (2018)

Fosfomycin in infections caused by multidrug-resistant Gram-negative pathogens
por: Ruiz Ramos, Jesús, et al.
Publicado: (2019)

2263. Fosfomycin Trometerol Use for Complicated UTIs Including Pyelonephritis, a 1-year Review of Outcomes and Prescribing Habits
por: Hatlen, Timothy J, et al.
Publicado: (2019)

Efficacy of Fosfomycin against Planktonic and Biofilm-Associated MDR Uropathogenic Escherichia coli Clinical Isolates
por: Dzib-Baak, Haziel Eleazar, et al.
Publicado: (2022)

Low-Avidity Autoantibodies against Bactericidal/Permeability-Increasing Protein Occur in Gram-Negative and Gram-Positive Bacteremia
por: Theprungsirikul, J., et al.
Publicado: (2020)

Evaluation of the utility of conventional polymerase chain reaction for detection and species differentiation in human hookworm infections
por: Chidambaram, Meenachi, et al.
Publicado: (2017)

The effect of varying multidrug-resistence (MDR) definitions on rates of MDR gram-negative rods
por: Wolfensberger, Aline, et al.
Publicado: (2019)

Assessment of the Susceptibility of Clinical Gram-Negative and Gram-Positive Bacterial Strains to Fosfomycin and Significance of This Antibiotic in Infection Treatment
por: Kowalska-Krochmal, Beata, et al.
Publicado: (2022)

1578. Treatments for complicated urinary tract infections (cUTI) caused by multidrug resistant (MDR) Gram-negative (GN) pathogens- a systematic review and network meta-analysis (NMA)
por: Reason, Tim, et al.
Publicado: (2020)

342. Multicenter Evaluation of Fosfomycin MIC Results for Enterobacterales Using EUCAST V11 Breakpoints (i.v. and oral for uncomplicated UTI only, E. coli) on MicroScan Dried Gram Negative MIC Panels
por: Garner, Omai, et al.
Publicado: (2022)

Authors’ Response to Peer Reviews of “Representing Physician Suicide Claims as Nanopublications: Proof-of-Concept Study Creating Claim Networks”
por: Leung, Tiffany I, et al.
Publicado: (2022)

Treatment of Infections Due to MDR Gram-Negative Bacteria
por: Bassetti, Matteo, et al.
Publicado: (2019)

In vitro Activity of Fosfomycin against Multidrug-Resistant Urinary and Nonurinary Gram-Negative Isolates
por: Behera, Bijayini, et al.
Publicado: (2018)

Widespread Fosfomycin Resistance in Gram-Negative Bacteria Attributable to the Chromosomal fosA Gene
por: Ito, Ryota, et al.
Publicado: (2017)

1242. Efficacy and Safety of Intravenous Fosfomycin for the Treatment of Multi-resistant Gram Negative Infections
por: Abdallah, Tasneem, et al.
Publicado: (2021)

1471. Medical Claims Analysis as a Tool to Evaluate Empiric and Targeted Antibiotic Therapy in UTIs
por: Hui, Wing, et al.
Publicado: (2019)

Early appropriate diagnostics and treatment of MDR Gram-negative infections
por: Bassetti, Matteo, et al.
Publicado: (2022)

Authors’ response
por: Pahari, S., et al.
Publicado: (2016)

Synergistic Effects from Combination of Cryptotanshinone and Fosfomycin Against Fosfomycin-Susceptible and Fosfomycin-Resistant Staphylococcus aureus
por: Ruan, Zijing, et al.
Publicado: (2020)

Fosfomycin and breastfeeding
Publicado: (2020)

Response: Basal C-peptide Level as a Surrogate Marker of Subclinical Atherosclerosis in Type 2 Diabetic Patients (Diabetes Metab J 2011;35:41-9)
por: Kim, Sung-Tae, et al.
Publicado: (2011)

Response: The Effect of an Angiotensin Receptor Blocker on Arterial Stiffness in Type 2 Diabetes Mellitus Patients with Hypertension (Diabetes Metab J 2011;35:236-42)
por: Kim, Ji Hyun, et al.
Publicado: (2011)

Response: Predictive Clinical Parameters for the Therapeutic Efficacy of Sitagliptin in Korean Type 2 Diabetes Mellitus (Diabetes Metab J 2011;35:159-65)
por: Kim, Soon Ae, et al.
Publicado: (2011)

Response: The Effects of Low-Calorie Diets on Abdominal Visceral Fat, Muscle Mass, and Dietary Quality in Obese Type 2 Diabetic Subjects (Korean Diabetes J 2009;33:526-36)
por: Ahn, Hee-Jung, et al.
Publicado: (2010)

Response: Prevalence of Dyslipidemia among Korean Adults: Korea National Health and Nutrition Survey 1998-2005 (Diabetes Metab J 2012;36:43-55)
por: Kim, Hyeon Chang
Publicado: (2012)

Response: Impact of HbA1c Criterion on the Detection of Subjects with Increased Risk for Diabetes among Health Check-Up Recipients in Korea (Diabetes Metab J 2012;36:151-6)
por: Kim, Hong-Kyu, et al.
Publicado: (2012)

Response: The Prevalence of Peripheral Arterial Disease in Korean Patients with Type 2 Diabetes Mellitus Attending a University Hospital (Diabetes Metab J 2011;35:543-50)
por: Yu, Ji Hee, et al.
Publicado: (2012)

Response: Higher Glycated Hemoglobin Level Is Associated with Increased Risk for Ischemic Stroke in Non-Diabetic Korean Male Adults (Diabetes Metab J 2011;35:551-7)
por: Oh, Hyung Geun, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_2qvl6jjion54erot2ldp855jf9